AI Drug Development Stocks Rally Early in Trading, METIS TECHBIO-P Jumps Over 13%, INWISEAI Up More Than 11%

Deep News
6 hours ago

Shares of companies focused on AI-driven pharmaceutical development experienced a broad uptick during the morning session, with several key players posting significant gains.

At the time of reporting, METIS TECHBIO-P (07666) surged by 13.20%, trading at HK$17.58, while INWISEAI (03696) climbed 10.98% to HK$59.65. Meanwhile, XtalPi Holdings (02228) advanced 8.34% to HK$7.47, and GenScript Biotech (01548) rose 6.39% to HK$39.60.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10